STOCK TITAN

Adagene to Present at the Biotech Showcase™ 2023 in San Francisco on January 9

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Adagene Inc. (Nasdaq: ADAG) announces that CEO Peter Luo will present a corporate update at the Biotech Showcase™ 2023 on January 9-11 in San Francisco, coinciding with the J.P. Morgan Healthcare Conference. The presentation is scheduled for 11:30 a.m. Pacific time at the Hilton San Francisco, Union Square. A live webcast will be available on Adagene's investor website, with a replay accessible for 30 days. Adagene focuses on developing novel antibody-based cancer immunotherapies using advanced technologies like its Dynamic Precision Library.

Positive
  • None.
Negative
  • None.

SAN DIEGO and SUZHOU, China, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, today announced that Adagene’s Co-founder, Chief Executive Officer and Chairman, Peter Luo, Ph.D., will provide a corporate update at the Biotech Showcase™ 2023, taking place January 9-11th in San Francisco, in parallel to the annual J.P. Morgan Healthcare Conference.

Details of the event are as follows:

Date:Monday, January 9th
Presentation Time:11:30 a.m. (Pacific time)
Location:Hilton San Francisco, Union Square

A live webcast of the presentation will also be accessible in the Investors section of the company’s website at https://www.adagene.com. A webcast replay will be available for at least 30 days.

For live attendance, please register at https://informaconnect.com/biotech-showcase/

About Adagene
Adagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Powered by its proprietary Dynamic Precision Library (DPL) platform, composed of NEObody™, SAFEbody®, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

For more information, please visit: https://investor.adagene.com. Follow Adagene on WeChatLinkedIn and Twitter.

SAFEbody® is a registered trademark in the United States, China, Australia, Japan, Singapore, and the European Union.


FAQ

What is the date of Adagene's presentation at the Biotech Showcase 2023?

Adagene's presentation is scheduled for January 9, 2023.

Who will present at the Biotech Showcase for Adagene?

CEO Peter Luo will provide a corporate update.

Where is the Biotech Showcase 2023 being held?

It will take place at the Hilton San Francisco, Union Square.

What time is Adagene's presentation at the Biotech Showcase?

The presentation is set for 11:30 a.m. Pacific time.

How can I access the webcast of Adagene's presentation?

The webcast will be available on Adagene's investor website.

How long will the webcast replay of Adagene's presentation be available?

The replay will be accessible for at least 30 days.

Adagene Inc. American Depositary Shares

NASDAQ:ADAG

ADAG Rankings

ADAG Latest News

ADAG Stock Data

79.69M
39.29M
10.66%
25.2%
0.15%
Biotechnology
Healthcare
Link
United States of America
Suzhou